Neuroblastoma cell death in response to docosahexaenoic acid: Sensitization to chemotherapy and arsenic‐induced oxidative stress

Abstract

Docosahexaenoic acid (DHA) is an x-3 polyunsaturated fatty acid vital for the developing nervous system and significantly decreased in neuroblastoma cells compared to nontransformed nervous tissue. We investigated whether supplementation of DHA affects the susceptibility of neuroblastoma cells to oxidative stress generated endogenously and in response to cytotoxic therapy. DHA, but not the monounsaturated oleic acid (OA), induced dose-and timedependent neuroblastoma cell death. DHA supplementation was associated with depolarization of the mitochondrial membrane potential, production of reactive oxygen species (ROS) and accumulation of DNA in sub-G1 phase of the cell cycle. The antioxidant, vitamin E, inhibited mitochondrial depolarization and subsequent cell death induced by DHA, whereas, the mitochondrial pore inhibitor, cyclosporin A, partly inhibited DHA-induced neuroblastoma cell death. Depletion of glutathione by L-buthioninesulfoximine significantly enhanced the cytotoxic effects of DHA. Nontransformed fibroblasts were not substantially affected by DHA. DHA, but not OA, significantly enhanced the cytotoxicity of cisplatin, doxorubicin and irinotecan both in chemosensitive and in multidrug-resistant neuroblastoma cells. DHA potently sensitized neuroblastoma cells to a clinically relevant concentration (1 lM) of arsenic trioxide (As 2 O 3 ) and enhanced the effect of the nonsteroidal antiinflammatory drug (NSAID), diclofenac. These findings provide experimental evidence that the x-3 fatty acid, DHA, is cytotoxic to drug-resistant neuroblastoma. The potent action of DHA with arsenic trioxide, NSAID and chemotherapeutic agents suggests clinical testing of this therapeutic concept in children with neuroblastoma. ' 2005 Wiley-Liss, Inc.

Chemical–Physical Changes in Cell Membrane Microdomains of Breast Cancer Cells After Omega-3 PUFA Incorporation

“…PUFA act with synergy to anticancer drugs in cells culture or in tumor-bearing animals, decreasing tumor size, reducing side effects and prolonging survival [26][27][28].…”

Tumor and non-tumor tissues differential oxidative stress response to supplemental DHA and chemotherapy in rats

“…We and others have reported that DHA or EPA enhancement of drug cytotoxicity to cancer cells or tumors was associated [6][7][8][9][10][11] or correlated [6,12] with an increase in the production of markers of oxidative stress, such as lipid hydroperoxides. Antioxidants abolished this eVect [6][7][8][12][13][14][15] while prooxidants increased it [12,14]. The feasibility of this approach has been conWrmed in two phase II clinical trials in advanced breast or lung cancers patients.…”

Effects of small molecule inhibitors of PI3K/Akt/mTOR signaling on neuroblastoma growth in vitro and in vivo

“…The mitochondrial transmembrane potential was assessed in SK-N-BE(2), SH-SY5Y, SK-N-SH, and SK-N-AS cells after 24 hr incubations with 1.5 lM OSU03012 or PI103 using tetramethylrhodamine ethyl ester (TMRE; Invitrogen, Carlsbad, CA) as previously described. 21 …”